Core Viewpoint - Zhendermedical's stock closed at 22.84 yuan, up 2.79%, with a rolling PE ratio of 16.76, marking a new low in 158 days, and a total market value of 6.086 billion yuan [1] Company Summary - Zhendermedical specializes in the research, production, and sales of medical and health products, focusing on basic care, surgical infection control, pressure treatment and fixation, ostomy and modern wound care, and infection control protection [1] - The company has received multiple technical awards, including provincial-level key enterprise research institutes and high-tech enterprise certifications, and has passed the national high-tech enterprise review [1] - For Q1 2025, Zhendermedical reported revenue of 999.2 million yuan, a year-on-year increase of 2.87%, and a net profit of 51.2419 million yuan, a year-on-year decrease of 30.19%, with a gross profit margin of 34.28% [1] Industry Summary - The average PE ratio for the medical device industry is 56.56, with a median of 39.76, placing Zhendermedical at 35th in the industry ranking [1] - As of Q1 2025, three institutions held shares in Zhendermedical, with a total of 1.4513 million shares valued at 3.1 million yuan [1] - The industry average market value is 11.897 billion yuan, with Zhendermedical's market value significantly lower at 6.086 billion yuan [2]
振德医疗收盘上涨2.79%,滚动市盈率16.76倍,总市值60.86亿元